Eli Lilly
$119.779876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$119.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.10 (+0.93%) Today
$0.00 (0.00%) As of 6:11 PM EST after-hours
Why Robinhood?
You can buy or sell Eli Lilly and other stocks, options, ETFs, and crypto commission-free!
About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. Read More The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.
Employees
38,680
Headquarters
Indianapolis, Indiana
Founded
1876
Market Cap
112.92B
Price-Earnings Ratio
26.29
Dividend Yield
1.94
Average Volume
2.73M
High Today
$119.92
Low Today
$117.54
Open Price
$118.19
Volume
3.00M
52 Week High
$132.13
52 Week Low
$101.36
Collections
LLY News
Reuters13h
Eli Lilly to put Loxo executives in charge of new cancer research unit
(Reuters) - U.S. drugmaker Eli Lilly and Co said on Thursday it will create a new cancer research division that will be run by top executives from Loxo Oncology
BenzingaDec 2
Global Attention Deficit Hyperactivity Disorder Market Spotlight 2019 Featuring Allergan, Eli Lilly, Johnson & Johnson, Takeda, Teva - ResearchAndMarkets.com
The "Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)?" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight repoAnalyst Ratings
43%
of 14 ratings
Buy
43%
Hold
57%
Sell
0%
LLY Earnings
$1.13
$1.25
$1.38
$1.50
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Available Jan 30, Pre-Market